Anti-Erk1 (pT202/pY204) + Erk2 (pT185/pY187) antibody
- Lab Essentials
- What is this?
3
(4 Reviews)
|
(35 Publications)
Rabbit Polyclonal ERK1 phospho T202 + Y204 antibody. Suitable for IHC-P, WB and reacts with Mouse, Human, Rat samples. Cited in 35 publications. Immunogen corresponding to Synthetic Peptide within Human MAPK1 phospho T185 + Y187.
View Alternative Names
ERK1, PRKM3, MAPK3, Mitogen-activated protein kinase 3, MAP kinase 3, MAPK 3, ERT2, Extracellular signal-regulated kinase 1, Insulin-stimulated MAP2 kinase, MAP kinase isoform p44, Microtubule-associated protein 2 kinase, p44-ERK1, ERK-1, p44-MAPK, ERK2, PRKM1, PRKM2, MAPK1, Mitogen-activated protein kinase 1, MAP kinase 1, MAPK 1, ERT1, Extracellular signal-regulated kinase 2, MAP kinase isoform p42, Mitogen-activated protein kinase 2, ERK-2, p42-MAPK, MAP kinase 2, MAPK 2
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Erk1 (pT202/pY204) + Erk2 (pT185/pY187) antibody (AB4819)
Immunohistochemical analysis of paraffin-embedded human breast carcinoma tissue (right) labeling ERK1/2 (pTpY185/187) in the cytoplasm and nucleus with ab4819 at 1/50 dilution, compared to a negative control without primary antibody (left).
To expose target proteins, antigen retrieval was performed using 10mM sodium citrate (pH 6.0), microwaved for 8-15 min. Following antigen retrieval, tissues were blocked in 3% H2O2-methanol for 15 min at room temperature, washed with ddH2O and PBS, and then probed with ab4819 diluted in 3% BSA-PBS at a dilution of 1 : 50 overnight at 4°C in a humidified chamber. Tissues were washed extensively in PBST and detection was performed using an HRP-conjugated secondary antibody followed by colorimetric detection using a DAB kit. Tissues were counterstained with hematoxylin and dehydrated with ethanol and xylene to prep for mounting.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Erk1 (pT202/pY204) + Erk2 (pT185/pY187) antibody (AB4819)
Immunohistochemical analysis of paraffin-embedded human colon carcinoma tissue (right) labeling ERK1/2 (pTpY185/187) in the cytoplasm and nucleus withab4819 at 1/20 dilution, compared to a negative control without primary antibody (left).
To expose target proteins, antigen retrieval was performed using 10mM sodium citrate (pH 6.0), microwaved for 8-15 min. Following antigen retrieval, tissues were blocked in 3% H2O2-methanol for 15 min at room temperature, washed with ddH2O and PBS, and then probed with ab4819 diluted in 3% BSA-PBS at a dilution of 1 : 20 overnight at 4°C in a humidified chamber. Tissues were washed extensively in PBST and detection was performed using an HRP-conjugated secondary antibody followed by colorimetric detection using a DAB kit. Tissues were counterstained with hematoxylin and dehydrated with ethanol and xylene to prep for mounting.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Erk1 (pT202/pY204) + Erk2 (pT185/pY187) antibody (AB4819)
Immunohistochemical analysis of paraffin-embedded mouse stomach tissue (right) labeling ERK1/2 (pTpY185/187) in the cytoplasm and nucleus with ab4819 at 1/20 dilution, compared to a negative control without primary antibody (left).
To expose target proteins, antigen retrieval was performed using 10mM sodium citrate (pH 6.0), microwaved for 8-15 min. Following antigen retrieval, tissues were blocked in 3% H2O2-methanol for 15 min at room temperature, washed with ddH2O and PBS, and then probed with ab4819 diluted in 3% BSA-PBS at a dilution of 1/20 overnight at 4°C in a humidified chamber. Tissues were washed extensively in PBST and detection was performed using an HRP-conjugated secondary antibody followed by colorimetric detection using a DAB kit. Tissues were counterstained with hematoxylin and dehydrated with ethanol and xylene to prep for mounting.
- WB
Supplier Data
Western blot - Anti-Erk1 (pT202/pY204) + Erk2 (pT185/pY187) antibody (AB4819)
Bands of 42 kDa and 44 kDa corresponding to Phospho-p44 MAPK + p42 MAPK pThr185 + pTyr187 was observed across cell lines tested. Known quantity of protein samples were electrophoresed using Novex® NuPAGE® 12 % Bis-Tris gel, XCell SureLock™ Electrophoresis System and Novex® Sharp Pre-Stained Protein Standard. Resolved proteins were then transferred onto a nitrocellulose membrane with iBlot® 2 Dry Blotting System. The membrane was probed with the relevant primary and secondary Antibody following blocking with 5 % skimmed milk. Chemiluminescent detection was performed using Pierce™ ECL Western Blotting Substrate.
All lanes:
Western blot - Anti-Erk1 (pT202/pY204) + Erk2 (pT185/pY187) antibody (ab4819) at 1/1000 dilution
Lane 1:
MDA-MB-231 (human breast adenocarcinoma cell line) whole cell lysate, with treatment of EGF(100 ng/mL for 15 mins) at 30 µg
Lane 2:
MDA-MB-231 whole cell lysate at 30 µg
Lane 3:
U-87 MG (human glioblastoma-astrocytoma epithelial cell line) whole cell lysate at 30 µg
Lane 4:
SH-SY5Y (human neuroblastoma cell line from bone marrow) whole cell lysate at 30 µg
Lane 5:
HeLa (human epithelial cell line from cervix adenocarcinoma) whole cell lysate at 30 µg
Predicted band size: 42 kDa,44 kDa
false
- WB
Supplier Data
Western blot - Anti-Erk1 (pT202/pY204) + Erk2 (pT185/pY187) antibody (AB4819)
Extracts of PC12 cells were resolved by SDS-PAGE on a 10% Tris-glycine gel and transferred to PVDF.
The membrane was blocked with a 5% BSA-TBST buffer overnight at 4°C, and then incubated with ab4819 for two hours at room temperature in a 3% BSA-TBST buffer, following its prior incubation with :
Lane 1 and 2 : no peptide
Lane 3 : the non-phosphopeptide corresponding to the phosphopeptide immunogen
Lane 4 : a generic phosphothreonine-containing peptide
Lane 5 : a generic phosphotyrosine-containing peptide
Labe 6 : the phosphopeptide immunogen
Detection : Pierce SuperSignal™ method.
All lanes:
Western blot - Anti-Erk1 (pT202/pY204) + Erk2 (pT185/pY187) antibody (ab4819) at 1/1000 dilution
Lane 1:
PC-12 (rat adrenal gland pheochromocytoma cell line) whole cell lysate, unstimulated
Lanes 2 - 6:
PC-12 whole cell lysate, stimulated with 0.5 M sorbitol for 5 minutes
Secondary
All lanes:
Goat F (ab')2 anti-rabbit IgG HRP conjugate
Predicted band size: 42 kDa,44 kDa
false
- WB
Supplier Data
Western blot - Anti-Erk1 (pT202/pY204) + Erk2 (pT185/pY187) antibody (AB4819)
Data was analyzed on the LI-COR Odyssey® Infrared Imaging System.
All lanes:
Western blot - Anti-Erk1 (pT202/pY204) + Erk2 (pT185/pY187) antibody (ab4819) at 1/1000 dilution
Lane 1:
NIH/3T3 (mouse embryonic fibroblast cell line) whole cell lysate at 20 µg
Lane 2:
NIH/3T3 whole cell lysate, treated with either PDGF at 20 µg
Secondary
All lanes:
Anti-rabbit secondary antibody conjugated to Alexa fluor 680
Predicted band size: 42 kDa,44 kDa
false
Reactivity data
Properties and storage information
Form
Purification technique
Purification notes
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Erk1 and Erk2 are involved in several essential cellular processes including proliferation differentiation and survival. They often operate as part of a larger complex engaging with other proteins to drive cellular responses. Upon activation they move from the cytoplasm to the nucleus where they regulate the activity of various transcription factors. Erk signaling can adjust gene expression by phosphorylating nuclear targets which influences cell cycle progression and apoptosis.
Pathways
Both Erk1 and Erk2 mainly operate within the MAPK/ERK pathway. This signaling pathway is important for transmitting signals from growth factors and other extracellular stimulants. Related proteins such as Ras and Raf are upstream activators in the pathway. Downstream Erk proteins can impact other cascades including those governing cellular growth and division. By interacting with multiple proteins within these pathways Erk1 and Erk2 ensure accurate cellular responses to environmental changes.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (35)
Recent publications for all applications. Explore the full list and refine your search
JCI insight 9: PubMed39436705
2024
Applications
Unspecified application
Species
Unspecified reactive species
Cell death & disease 15:365 PubMed38806451
2024
Applications
Unspecified application
Species
Unspecified reactive species
Oncology letters 22:782 PubMed34594423
2021
Applications
Unspecified application
Species
Unspecified reactive species
Blood cancer journal 11:111 PubMed34099621
2021
Applications
Unspecified application
Species
Unspecified reactive species
Aging 13:9348-9372 PubMed33744867
2021
Applications
Unspecified application
Species
Unspecified reactive species
Antioxidants (Basel, Switzerland) 9: PubMed33158256
2020
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in cell and developmental biology 8:555378 PubMed33072743
2020
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular sciences 21: PubMed32967113
2020
Applications
Unspecified application
Species
Unspecified reactive species
Investigative ophthalmology & visual science 61:21 PubMed32301972
2020
Applications
Unspecified application
Species
Unspecified reactive species
Journal of cellular physiology 235:6268-6286 PubMed31990070
2020
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com